- Home
- ATYR vs MGPI Comparison
ATYR vs MGPI Comparison
Compare ATYR & MGPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- MGPI
- Stock Information
- Founded
- ATYR 2005
- MGPI 1941
- Country
- ATYR United States
- MGPI United States
- Employees
- ATYR 59
- MGPI N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- MGPI Beverages (Production/Distribution)
- Sector
- ATYR Health Care
- MGPI Consumer Staples
- Exchange
- ATYR Nasdaq
- MGPI Nasdaq
- Market Cap
- ATYR 105.8M
- MGPI 610.9M
- IPO Year
- ATYR 2015
- MGPI 1988
- Fundamental
- Price
- ATYR $1.03
- MGPI $27.57
- Analyst Decision
- ATYR Buy
- MGPI Strong Buy
- Analyst Count
- ATYR 6
- MGPI 5
- Target Price
- ATYR $8.88
- MGPI $45.40
- AVG Volume (30 Days)
- ATYR 15.6M
- MGPI 186.0K
- Earning Date
- ATYR 11-06-2025
- MGPI 10-30-2025
- Dividend Yield
- ATYR N/A
- MGPI 1.75%
- EPS Growth
- ATYR N/A
- MGPI N/A
- EPS
- ATYR N/A
- MGPI N/A
- Revenue
- ATYR N/A
- MGPI $609,404,000.00
- Revenue This Year
- ATYR $420.85
- MGPI N/A
- Revenue Next Year
- ATYR $1,919.44
- MGPI N/A
- P/E Ratio
- ATYR N/A
- MGPI N/A
- Revenue Growth
- ATYR N/A
- MGPI N/A
- 52 Week Low
- ATYR $0.97
- MGPI $25.12
- 52 Week High
- ATYR $7.29
- MGPI $86.35
- Technical
- Relative Strength Index (RSI)
- ATYR 22.25
- MGPI 40.60
- Support Level
- ATYR $1.00
- MGPI $27.50
- Resistance Level
- ATYR $6.50
- MGPI $28.45
- Average True Range (ATR)
- ATYR 0.46
- MGPI 0.81
- MACD
- ATYR -0.51
- MGPI -0.12
- Stochastic Oscillator
- ATYR 1.01
- MGPI 7.84
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.